Chargement en cours...
Review of miglustat for clinical management in Gaucher disease type 1
Gaucher disease is a progressive lysosomal storage disorder caused by the deficiency of glucocerebrosidase, and characterized by intralysosomal storage of glucosylceramide that leads to dysfunction in multiple organ systems. Intravenous enzyme replacement with imiglucerase is the accepted standard f...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2504062/ https://ncbi.nlm.nih.gov/pubmed/18728838 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|